Innovating Works

VIROPLANT

Financiado
VIROME NGS ANALYSIS OF PESTS AND PATHOGENS FOR PLANT PROTECTION
Next generation sequencing (NGS) technology has proved to be pivotal for elucidating the complexity and the role of the microbiome associated with plant and animals. The role of the virome as a sub-component of the microbiome is b... Next generation sequencing (NGS) technology has proved to be pivotal for elucidating the complexity and the role of the microbiome associated with plant and animals. The role of the virome as a sub-component of the microbiome is beginning to be unveiled because of new ways to analyse the data and in recognition of its importance in shaping biological systems. The aim of VIROPLANT is to apply NGS technology and empirical biological experiments to develop new environmentally friendly virus-based control strategies to manage bacterial, fungal and insect vector-transmitted diseases (phytoplasmas and viruses) as well as insect pests. So far, plant protection through viruses has relied on limited successful model systems, such as baculoviruses for lepidopterans, and one mycovirus for the control of chestnut blight; moreover, viruses infecting bacteria (phages) are also state of the art tools with potential to cope with antibiotic resistant bacterial strains in human and veterinary medicine. VIROPLANT will create a database of new viruses (and virus derived biotechnological products) to increase the arsenal for the control of plant diseases caused by the most important biotic stresses. Different NGS and bioinformatics approaches will be applied to explore the virome diversity, including latent infections that can be potentially exploited for new biocontrol strategies. Protocols of risk assessment will be implemented for virome-based model control strategies. VIROPLANT will address the social and gender-specific perception of the use of virome-based techniques as alternatives to traditional pesticides. A business plan for representative categories of virome-based control strategies will be included. Small and medium enterprises and stakeholders will be involved in bringing the most promising products to the market. The consortium will cover experts in insect virome, phage therapy and mycoviruses from different agro-ecological systems throughout Europe. ver más
31/10/2021
CNR
3M€
Duración del proyecto: 42 meses Fecha Inicio: 2018-04-27
Fecha Fin: 2021-10-31

Línea de financiación: concedida

El organismo H2020 notifico la concesión del proyecto el día 2021-10-31
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
SFS-17-2017: Innovations in plant protection
Cerrada hace 7 años
Presupuesto El presupuesto total del proyecto asciende a 3M€
Líder del proyecto
CONSIGLIO NAZIONALE DELLE RICERCHE No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5